J.Henderson Gl.Life Sciences F.I2/  IE0002141913  /

Fonds
NAV3/1/2024 Chg.+1.0600 Type of yield Investment Focus Investment company
66.8200USD +1.61% reinvestment Equity Worldwide Janus Henderson Inv. 
 

Investment goal

The Fund seeks long - term growth of capital by investing primarily in life - science equity securities of companies located anywhere in the world and selected for their growth potential.
 

Master data

Type of yield: reinvestment
Funds Category: Equity
Region: Worldwide
Branch: Sector Health / Pharma
Benchmark: MSCI World Healthcare Index
Business year start: 1/1
Last Distribution: -
Depository bank: J.P. Morgan SE Dublin Branch
Fund domicile: Ireland
Distribution permission: Austria, Germany, Switzerland, United Kingdom
Fund manager: Andy Acker, Daniel Lyons
Fund volume: 4.06 bill.  USD
Launch date: 3/31/2000
Investment focus: -

Conditions

Issue surcharge: 2.00%
Max. Administration Fee: 1.50%
Minimum investment: 1,000,000.00 USD
Deposit fees: -
Redemption charge: 0.00%
Key Investor Information: Download (Print version)
 

Investment company

Funds company: Janus Henderson Inv.
Address: 201 Bishopsgate, EC2M 3AE, London
Country: United Kingdom
Internet: www.janushenderson.com/
 

Assets

Stocks
 
99.74%
Cash
 
0.24%
Others
 
0.02%

Countries

United States of America
 
72.60%
Denmark
 
5.99%
United Kingdom
 
4.29%
Switzerland
 
3.82%
France
 
2.67%
Ireland
 
2.32%
Japan
 
1.65%
Netherlands
 
1.56%
Virgin Islands (British)
 
1.00%
China
 
0.90%
Cayman Islands
 
0.33%
Cash
 
0.24%
Canada
 
0.23%
Others
 
2.40%

Branches

Pharma/Biotechnology
 
60.91%
Healthcare appliances
 
17.46%
Healthcare services
 
17.35%
Parma, wholesale
 
1.63%
Cash
 
0.24%
Others
 
2.41%